# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001654954-18-011065
Filing Date
2018-10-12
Accepted
2018-10-12 16:18:06
Documents
8
Period of Report
2018-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | gtbp_8k.htm | 8-K | 29622
2 | SEPARATION AGREEMENT | gtbp_ex101.htm | EX-10.1 | 6075
3 | IMAGE | gtbp_ex101000.jpg | GRAPHIC | 106592
4 | IMAGE | gtbp_ex101001.jpg | GRAPHIC | 128322
5 | IMAGE | gtbp_ex101002.jpg | GRAPHIC | 126054
6 | IMAGE | gtbp_ex101003.jpg | GRAPHIC | 82862
7 | IMAGE | gtbp_ex101004.jpg | GRAPHIC | 83102
8 | IMAGE | gtbp_ex101005.jpg | GRAPHIC | 24027
| Complete submission text file | 0001654954-18-011065.txt |  | 796793

Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 181120405
SIC: 2834 Pharmaceutical Preparations